HDAC Inhibitors in Cancer Care.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 180
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2010 AND VI 24 AND IP 2
Results: 25
1
2
Improving Our Use and Understanding of Antibodies in B-cell Lymphomas.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 176
- By:
- Publication type:
- Article
3
Integrative oncology: complementary therapies, herbs, and other OTC agents. Gerson regimen.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Continuing medical education.
- Published in:
- 2010
- Publication type:
- Journal Article
5
The Shabason/Tofilon/Camphausen article reviewed. HDAC inhibitor research: still in its infancy.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
6
The Shabason/Tofilon/Camphausen article reviewed. HDAC inhibitors: much to learn about effective therapy.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
7
HDAC inhibitors in cancer care.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
8
Monoclonal antibodies in advanced B-cell lymphomas.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
9
The Ujjani/Cheson article reviewed. 'Vitamin R' and its younger siblings.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
10
The Ujjani/Cheson article reviewed. Improving our use and understanding of antibodies in B-cell lymphomas.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
11
Research reports. Proteomics study reveals a protein tied to taxane resistance.
- Published in:
- 2010
- Publication type:
- Journal Article
12
Research reports. Costs play role in oncologists' treatment recommendations, but most physicians do not discuss cost issues with patients.
- Published in:
- 2010
- Publication type:
- Journal Article
13
The Connolly/Stearns article reviewed. Clarifying the role of neoadjuvant therapy in breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
14
A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer: challenges and opportunities.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
15
Announcements.
- Published in:
- 2010
- Publication type:
- Journal Article
16
INTEGRATIVE ONCOLOGY: Complementary Therapies, Herbs, and Other OTC Agents.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 201
- By:
- Publication type:
- Article
17
Fighting a Smarter War on Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 193
- By:
- Publication type:
- Article
18
HDAC Inhibitor Research: Still in Its Infancy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 188
- By:
- Publication type:
- Article
19
HDAC Inhibitors: Much to Learn About Effective Therapy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 185
- By:
- Publication type:
- Article
20
Announcements.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 119
- Publication type:
- Article
21
`Vitamin R' and Its Younger Siblings.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 171
- By:
- Publication type:
- Article
22
Monoclonal Antibodies in Advanced B-cell Lymphomas.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 156
- By:
- Publication type:
- Article
23
RESEARCH REPORTS.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 153
- Publication type:
- Article
24
Clarifying the Role of Neoadjuvant Therapy in Breast Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 149
- By:
- Publication type:
- Article
25
A Multidisciplinary Approach to Neoadjuvant Therapy for Primary Operable Breast Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 2, p. 135
- By:
- Publication type:
- Article